ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $17,687,000 | +5623.9% | 381,771 | +2909.9% | 0.12% | +3966.7% |
| Q1 2019 | $309,000 | +67.9% | 12,684 | +15.6% | 0.00% | +50.0% |
| Q2 2018 | $184,000 | -29.8% | 10,973 | -31.7% | 0.00% | 0.0% |
| Q1 2018 | $262,000 | -70.2% | 16,065 | -77.6% | 0.00% | -75.0% |
| Q3 2017 | $880,000 | +490.6% | 71,582 | +301.0% | 0.01% | +700.0% |
| Q2 2017 | $149,000 | -58.3% | 17,851 | -55.4% | 0.00% | -66.7% |
| Q1 2017 | $357,000 | -38.3% | 39,987 | -39.3% | 0.00% | -40.0% |
| Q4 2016 | $579,000 | +751.5% | 65,926 | +555.3% | 0.01% | +400.0% |
| Q3 2016 | $68,000 | +15.3% | 10,061 | -49.9% | 0.00% | – |
| Q1 2016 | $59,000 | -61.9% | 20,080 | -40.9% | 0.00% | -100.0% |
| Q3 2015 | $155,000 | +55.0% | 34,003 | +144.5% | 0.00% | 0.0% |
| Q2 2015 | $100,000 | -19.4% | 13,907 | -17.1% | 0.00% | 0.0% |
| Q1 2015 | $124,000 | +20.4% | 16,779 | -22.7% | 0.00% | 0.0% |
| Q4 2014 | $103,000 | -24.8% | 21,700 | -1.4% | 0.00% | 0.0% |
| Q3 2013 | $137,000 | -60.2% | 22,007 | -71.0% | 0.00% | -50.0% |
| Q2 2013 | $344,000 | – | 75,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |